These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28088966)

  • 1. [Delayed hematologic response to immunosuppressive therapy in severe aplastic anemia].
    Yang Y; Yang WR; Wu ZJ; Zhao X; Zhang L; Jing LP; Zhou K; Li Y; Peng GX; Li Y; Li JP; Song L; Ye L; Fan HH; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1038-1043. PubMed ID: 28088966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reassessing the six months prognosis of patients with severe or very severe aplastic anemia without hematological responses at three months after immunosuppressive therapy].
    Hu XR; Zhao X; Zhang L; Jing LP; Yang WR; Li Y; Ye L; Zhou K; Li JP; Peng GX; Fan HH; Li Y; Yang Y; Xiong YZ; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2022 May; 43(5):393-399. PubMed ID: 35680597
    [No Abstract]   [Full Text] [Related]  

  • 3. [Outcomes of very severe aplastic anemia patients with different absolute neutrophil counts after frontline immnunosuppressive therapy].
    Li Y; Wu Z; Zhao X; Zhang L; Jing L; Zhou K; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Yang W; Jiang B; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):329-33. PubMed ID: 27093998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of immunosuppressive therapy for severe aplastic anemia patients with absolute neutrophil count of zero.
    Liu J; Lu XY; Cheng L; Yang Y; Lin SY; Yin H; Liu XQ; Wu XM; He GS
    Hematology; 2019 Dec; 24(1):492-497. PubMed ID: 31221029
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of pre-immunosupressive therapy iron overload on hematologic response of severe aplastic anemia].
    Ye L; Jing L; Peng G; Zhou K; Li Y; Li Y; Li J; Fan H; Yang W; Zhang F; Zhang L
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):324-8. PubMed ID: 27093997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects and Predictive Factors of Immunosuppressive Therapy Combined with Umbilical Cord Blood Infusion in Patients with Severe Aplastic Anemia.
    Zhang X; Li Z; Geng W; Song B; Wan C
    Yonsei Med J; 2018 Jul; 59(5):643-651. PubMed ID: 29869462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study.
    Liu Q; Dong H; Li Y; Shen Y; Hong Y; Chen Y; Liu S; Wu X; Liu W; Hu H; Zhao Y; Lin S; Shen Y; Zhou Y; Ye B; Wu D
    Lipids Health Dis; 2022 Oct; 21(1):93. PubMed ID: 36192750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia.
    Scheinberg P; Wu CO; Nunez O; Young NS
    Br J Haematol; 2009 Jan; 144(2):206-16. PubMed ID: 19036108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
    Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
    Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunosuppressive therapy using antithymocyte globulin and cyclosporin A with or without human granulocyte colony-stimulating factor in children with acquired severe aplastic anemia].
    Liu X; Zou Y; Wang S; Zhang L; Yang W; Zhang J; Liu F; Liu T; Chen X; Ruan M; Zhou J; Cai X; Qi B; Chang L; An W; Guo Y; Chen Y; Zhu X
    Zhonghua Er Ke Za Zhi; 2014 Feb; 52(2):84-9. PubMed ID: 24739716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increasing peripheral blood neutrophils after G-CSF treatment is a predictor of early response to immunosuppressive therapy in severe aplastic anemia].
    Wu Z; Yang W; Zhang L; Jing L; Zhou K; Li Y; Peng G; Ye L; Li Y; Li J; Fan H; Song L; Zhao X; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):974-9. PubMed ID: 25417872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag.
    Li R; Zhou J; Liu Z; Chen X; Long Q; Yang Y; Lin S; Jia J; He G; Li J
    Front Immunol; 2022; 13():884312. PubMed ID: 35720405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between Changes of Lymphocyte Subsets and Early Hematologic Response in Immunosuppressive Therapy of Severe Aplastic Anemia Patients].
    Li Y; Peng GX; Ye L; Li Y; Li JP; Fan HH; Song L; Yang WR; Yang Y; Zhou K; Zhang L; Jing LP; Zhao X; Zhang FK
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):207-212. PubMed ID: 33554821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.
    Rosenfeld S; Follmann D; Nunez O; Young NS
    JAMA; 2003 Mar; 289(9):1130-5. PubMed ID: 12622583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eltrombopag, oral immunosuppressant and androgen combination therapy in twelve patients with refractory severe aplastic anemia.
    Gao Q; Zhang L; Zhao X; Zhu Y; Peng G; Li Y; Li Y; Li J; Song L; Ye L; Fan H; Zhou K; Yang W; Yang Y; Jing L; Zhang F
    Hematology; 2020 Dec; 25(1):341-347. PubMed ID: 32915111
    [No Abstract]   [Full Text] [Related]  

  • 16. [Residual hematopoiesis is an important prognostic factor of immunosuppressive therapy in severe aplastic anemia].
    Yang W; Wu Z; Zhao X; Jing L; Zhang L; Zhou K; Peng G; Li Y; Ye L; Li Y; Li J; Fan H; Song L; Zhang F
    Zhonghua Xue Ye Xue Za Zhi; 2014 Dec; 35(12):1095-9. PubMed ID: 25543704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of concentration of cyclosporine A on the early response to immunosuppressive therapy in severe aplastic anemia].
    Liang LY; Zhang L; Jing LP; Zhou K; Wang XD; Li Y; Peng GX; Li Y; Li JP; Shi LH; Ye L; Fan HH; Zhang P; Chu YL; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2011 Nov; 32(11):766-71. PubMed ID: 22339914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells in peripheral blood at diagnosis predict response to immunosuppressive therapy in severe aplastic anemia.
    Yu W; Wang Q; Ge M; Shi X
    Clin Exp Med; 2023 Sep; 23(5):1815-1822. PubMed ID: 36244022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapse and clonal disease in children with aplastic anemia (AA) after immunosuppressive therapy (IST): the SAA 94 experience. German/Austrian Pediatric Aplastic Anemia Working Group.
    Führer M; Burdach S; Ebell W; Gadner H; Haas R; Harbott J; Janka-Schaub G; Klingebiel T; Kremens B; Niemeyer C; Rampf U; Reiter A; Ritter J; Schulz A; Walther U; Zeidler C; Bender-Götze C
    Klin Padiatr; 1998; 210(4):173-9. PubMed ID: 9743949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?
    Song MK; Chung JS; Joo YD; Kim YS; Kim SH; Seol YM; Shin HJ; Choi YJ; Cho GJ
    Eur J Haematol; 2009 Jul; 83(1):72-8. PubMed ID: 19220415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.